Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salicylaldehyde derivatives as new protein kinase CK2 inhibitors.
Prudent R, López-Ramos M, Moucadel V, Barette C, Grierson D, Mouawad L, Florent JC, Lafanechère L, Schmidt F, Cochet C. Prudent R, et al. Biochim Biophys Acta. 2008 Dec;1780(12):1412-20. doi: 10.1016/j.bbagen.2008.06.010. Epub 2008 Jul 7. Biochim Biophys Acta. 2008. PMID: 18674590
Expanding the chemical diversity of CK2 inhibitors.
Prudent R, Moucadel V, López-Ramos M, Aci S, Laudet B, Mouawad L, Barette C, Einhorn J, Einhorn C, Denis JN, Bisson G, Schmidt F, Roy S, Lafanechere L, Florent JC, Cochet C. Prudent R, et al. Mol Cell Biochem. 2008 Sep;316(1-2):71-85. doi: 10.1007/s11010-008-9828-z. Epub 2008 Jun 18. Mol Cell Biochem. 2008. PMID: 18563535
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
López-Ramos M, Prudent R, Moucadel V, Sautel CF, Barette C, Lafanechère L, Mouawad L, Grierson D, Schmidt F, Florent JC, Filippakopoulos P, Bullock AN, Knapp S, Reiser JB, Cochet C. López-Ramos M, et al. FASEB J. 2010 Sep;24(9):3171-85. doi: 10.1096/fj.09-143743. Epub 2010 Apr 16. FASEB J. 2010. PMID: 20400536
Progress toward JAK1-selective inhibitors.
Menet CJ, Mammoliti O, López-Ramos M. Menet CJ, et al. Future Med Chem. 2015;7(2):203-35. doi: 10.4155/fmc.14.149. Future Med Chem. 2015. PMID: 25686006 Review.
Design of a potent and selective dual JAK1/TYK2 inhibitor.
Mammoliti O, Menet C, Cottereaux C, Blanc J, De Blieck A, Coti G, Geney R, Oste L, Ostyn K, Palisse A, Quinton E, Schmitt B, Borgonovi M, Parent I, Jagerschmidt C, De Vos S, Vayssiere B, López-Ramos M, Shoji K, Brys R, Amantini D, Galien R, Joannesse C. Mammoliti O, et al. Among authors: lopez ramos m. Bioorg Med Chem. 2024 Nov 15;114:117932. doi: 10.1016/j.bmc.2024.117932. Epub 2024 Sep 30. Bioorg Med Chem. 2024. PMID: 39447537 Free article.
Off-label use of dalbavancin in children: a case series.
Gamell A, Velasco-Arnaiz E, López-Ramos MG, Ríos-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A, Fortuny C. Gamell A, et al. Among authors: lopez ramos mg. J Antimicrob Chemother. 2024 Aug 1;79(8):2062-2067. doi: 10.1093/jac/dkae212. J Antimicrob Chemother. 2024. PMID: 38958260 Free PMC article.
Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.
Mammoliti O, Martina S, Claes P, Coti G, Blanque R, Jagerschmidt C, Shoji K, Borgonovi M, De Vos S, Marsais F, Oste L, Quinton E, López-Ramos M, Amantini D, Brys R, Jimenez JM, Galien R, van der Plas S. Mammoliti O, et al. Among authors: lopez ramos m. J Med Chem. 2024 Jun 13;67(11):8545-8568. doi: 10.1021/acs.jmedchem.4c00769. Epub 2024 May 28. J Med Chem. 2024. PMID: 38805213 Free PMC article. Clinical Trial.
Lung ultrasound and procalcitonin, improving antibiotic management and avoiding radiation exposure in pediatric critical patients with bacterial pneumonia: a randomized clinical trial.
Guitart C, Bobillo-Perez S, Rodríguez-Fanjul J, Carrasco JL, Brotons P, López-Ramos MG, Cambra FJ, Balaguer M, Jordan I. Guitart C, et al. Among authors: lopez ramos mg. Eur J Med Res. 2024 Apr 6;29(1):222. doi: 10.1186/s40001-024-01712-y. Eur J Med Res. 2024. PMID: 38581075 Free PMC article. Clinical Trial.
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.
Peixoto C, Joncour A, Temal-Laib T, Tirera A, Dos Santos A, Jary H, Bucher D, Laenen W, Pereira Fernandes A, Lavazais S, Delachaume C, Merciris D, Saccomani C, Drennan M, López-Ramos M, Wakselman E, Dupont S, Borgonovi M, Roca Magadan C, Monjardet A, Brys R, De Vos S, Andrews M, Jimenez JM, Amantini D, Desroy N. Peixoto C, et al. Among authors: lopez ramos m. J Med Chem. 2024 Apr 11;67(7):5233-5258. doi: 10.1021/acs.jmedchem.3c02246. Epub 2024 Mar 29. J Med Chem. 2024. PMID: 38552030 Free PMC article.
39 results